APA

Wakshull E., Brunke-Reese D., Lindermuth J., Fisette L., Nathans R. S., Crowley J. J., Tufts J. C., Zimmerman J., Mackin W. & Adams D. S. (19990602). PGG-glucan, a soluble beta-(1,3)-glucan, enhances the oxidative burst response, microbicidal activity, and activates an NF-kappa B-like factor in human PMN: evidence for a glycosphingolipid beta-(1,3)-glucan receptor. : Immunopharmacology.

Chicago

Wakshull E, Brunke-Reese D, Lindermuth J, Fisette L, Nathans R S, Crowley J J, Tufts J C, Zimmerman J, Mackin W and Adams D S. 19990602. PGG-glucan, a soluble beta-(1,3)-glucan, enhances the oxidative burst response, microbicidal activity, and activates an NF-kappa B-like factor in human PMN: evidence for a glycosphingolipid beta-(1,3)-glucan receptor. : Immunopharmacology.

Harvard

Wakshull E., Brunke-Reese D., Lindermuth J., Fisette L., Nathans R. S., Crowley J. J., Tufts J. C., Zimmerman J., Mackin W. and Adams D. S. (19990602). PGG-glucan, a soluble beta-(1,3)-glucan, enhances the oxidative burst response, microbicidal activity, and activates an NF-kappa B-like factor in human PMN: evidence for a glycosphingolipid beta-(1,3)-glucan receptor. : Immunopharmacology.

MLA

Wakshull E, Brunke-Reese D, Lindermuth J, Fisette L, Nathans R S, Crowley J J, Tufts J C, Zimmerman J, Mackin W and Adams D S. PGG-glucan, a soluble beta-(1,3)-glucan, enhances the oxidative burst response, microbicidal activity, and activates an NF-kappa B-like factor in human PMN: evidence for a glycosphingolipid beta-(1,3)-glucan receptor. : Immunopharmacology. 19990602.